English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/219723
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions

AuthorsValent, Peter; Orazi, Attilio; Savona, Michael R.; Patnaik, Mrinal M.; Onida, Francesco; Loosdrecht, Arjan A. van de; Haase, Detlef; Haferlach T.; Elena, Chiara; Pleyer, Lisa; Kern, Wolfgang; Pemovska, Tea; Vladimer, Gregory I.; Schanz, Julie; Keller, Alexandra; Lübbert, Michael; Lion, Thomas; Sotlar, Karl; Reiter, Andreas; De Witte, Theo; Pfeilstöcker, Michael; Geissler, Klaus; Padron, Eric; Deininger, Michael; Orfao, Alberto ; Horny, Hans-Peter; Greenberg, Peter; Arber, Daniel A.; Malcovati, Luca; Bennett, John M.
Issue Date2019
PublisherFerrata Storti Foundation
CitationHaematologica 104(10): 1935–1949 (2019)
AbstractChronic myelomonocytic leukemia (CMML) is a myeloid neoplasm characterized by dysplasia, abnormal production and accumulation of monocytic cells and an elevated risk of transforming into acute leukemia. Over the past two decades, our knowledge about the pathogenesis and molecular mechanisms in CMML has increased substantially. In parallel, better diagnostic criteria and therapeutic strategies have been developed. However, many questions remain regarding prognostication and optimal therapy. In addition, there is a need to define potential pre-phases of CMML and special CMML variants, and to separate these entities from each other and from conditions mimicking CMML. To address these unmet needs, an international consensus group met in a Working Conference in August 2018 and discussed open questions and issues around CMML, its variants, and pre-CMML conditions. The outcomes of this meeting are summarized herein and include diag nostic criteria and a proposed classification of pre-CMML conditions as well as refined minimal diagnostic criteria for classical CMML and special CMML variants, including oligomonocytic CMML and CMML associated with systemic mastocytosis. Moreover, we propose diagnostic standards and tools to distinguish between ‘normal’, pre-CMML and CMML entities. These criteria and standards should facilitate diagnostic and prognostic evaluations in daily practice and clinical studies in applied hematology.
Publisher version (URL)https://doi.org/10.3324/haematol.2019.222059
URIhttp://hdl.handle.net/10261/219723
DOIhttp://dx.doi.org/10.3324/haematol.2019.222059
ISSN0390-6078
E-ISSN1592-8721
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
propoCMML.pdf380,88 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.